Patents by Inventor John Prescott
John Prescott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9505810Abstract: The present disclosure relates to novel pore-forming toxins of Type A C. perfringens and immunogenic compositions and vaccines thereof. The present disclosure further relates to methods and uses of treating or preventing enteric disease and assays for diagnosing enteric disease.Type: GrantFiled: August 21, 2015Date of Patent: November 29, 2016Assignee: University of GuelphInventors: John Prescott, Iman Mehdizadeh Gohari, Valeria Parreira Pinto
-
Patent number: 9493519Abstract: The present disclosure relates to a novel toxin of Type A C. perfringens and immunogenic compositions and vaccines thereof. The present disclosure further relates to methods and uses of treating or preventing enteric disease and assays for diagnosing enteric disease in mammals.Type: GrantFiled: May 23, 2013Date of Patent: November 15, 2016Assignee: University of GuelphInventors: John Prescott, Iman Mehdizadeh Gohari, Valeria Parreira Pinto
-
Patent number: 9399058Abstract: There is provided a vaccine for controlling Clostridium perfringens in animals, and particularly necrotic enteritis in poultry. The vaccine may comprise a C. perfringens antigenic polypeptide or variant thereof, a nucleic acid encoding the C. perfringens antigenic polypeptide or variant thereof, or a recombinant cell producing the C. perfringens antigenic polypeptide or variant thereof.Type: GrantFiled: July 22, 2013Date of Patent: July 26, 2016Assignee: University of GuelphInventors: John Prescott, Raveendra Kulkarni, Valeria Parreira, Shayan Sharif
-
Publication number: 20160052977Abstract: The present disclosure relates to novel pore-forming toxins of Type A C. perfringens and immunogenic compositions and vaccines thereof. The present disclosure further relates to methods and uses of treating or preventing enteric disease and assays for diagnosing enteric disease.Type: ApplicationFiled: August 21, 2015Publication date: February 25, 2016Inventors: John Prescott, Iman Mehdizadeh Gohari, Valeria Parreira Pinto
-
Publication number: 20150158917Abstract: The present disclosure relates to a novel toxin of Type A C. perfringens and immunogenic compositions and vaccines thereof. The present disclosure further relates to methods and uses of treating or preventing enteric disease and assays for diagnosing enteric disease in mammals.Type: ApplicationFiled: May 23, 2013Publication date: June 11, 2015Inventors: John Prescott, Iman Mehdizadeh Gohari, Valeria Parreira Pinto
-
Patent number: 8660875Abstract: A method and system for automated corrective and predictive maintenance is described herein. In one embodiment, a failure notification associated with a tool is received, wherein the failure notification indicates one or more failure events for the tool. Maintenance data associated with the tool is obtained, wherein the maintenance data includes one or more maintenance events for the tool. An optimal schedule is created for the tool by merging the failure notification and the maintenance data.Type: GrantFiled: November 1, 2010Date of Patent: February 25, 2014Assignee: Applied Materials, Inc.Inventors: Manjunath Yedatore, Deepak Bhatia, John Prescott
-
Publication number: 20130295127Abstract: There is provided a vaccine for controlling Clostridium perfringens in animals, and particularly necrotic enteritis in poultry. The vaccine may comprise a C. perfringens antigenic polypeptide or variant thereof, a nucleic acid encoding the C. perfringens antigenic polypeptide or variant thereof, or a recombinant cell producing the C. perfringens antigenic polypeptide or variant thereof.Type: ApplicationFiled: July 22, 2013Publication date: November 7, 2013Inventors: John Prescott, Raveendra Kulkarni, Valeria Parreira, Shayan Sharif
-
Patent number: 8501190Abstract: There is provided a vaccine for controlling Clostridium perfringens in animals, and particularly necrotic enteritis in poultry. The vaccine may comprise a C. perfringens antigenic polypeptide or variant thereof, a nucleic acid encoding the C. perfringens antigenic polypeptide or variant thereof, or a recombinant cell producing the C. perfringens antigenic polypeptide or variant thereof.Type: GrantFiled: May 30, 2008Date of Patent: August 6, 2013Assignee: The University of GuelphInventors: John Prescott, Raveendra Kulkarni, Valeria Parreira, Shayan Sharif
-
Publication number: 20110137697Abstract: A method and system for automated corrective and predictive maintenance is described herein. In one embodiment, a failure notification associated with a tool is received, wherein the failure notification indicates one or more failure events for the tool. Maintenance data associated with the tool is obtained, wherein the maintenance data includes one or more maintenance events for the tool. An optimal schedule is created for the tool by merging the failure notification and the maintenance data.Type: ApplicationFiled: November 1, 2010Publication date: June 9, 2011Inventors: MANJUNATH YEDATORE, Deepak Bhatia, John Prescott
-
Publication number: 20110086837Abstract: The invention relates methods of treating a patient with locally advanced or metastatic solid tumors with a combination of an inhibitor of phosphatidylinositol 3-kinase (PI 3-kinase or PI3K) and an inhibitor of mitogen activated protein kinase (MEK) described herein.Type: ApplicationFiled: October 11, 2010Publication date: April 14, 2011Applicant: Genentech, Inc.Inventors: Marcia Belvin, Iris T. Chan, Lori Friedman, Klaus P. Hoeflich, John Prescott, Jeffrey Wallin
-
Publication number: 20100255022Abstract: There is provided a vaccine for controlling Clostridium perfringens in animals, and particularly necrotic enteritis in poultry. The vaccine may comprise a C. perfringens antigenic polypeptide or variant thereof, a nucleic acid encoding the C. perfringens antigenic polypeptide or variant thereof, or a recombinant cell producing the C. perfringens antigenic polypeptide or variant thereof.Type: ApplicationFiled: May 30, 2008Publication date: October 7, 2010Applicant: UNIVERSITY OF GUELPHInventors: John Prescott, Raveendra Kulkarni, Valeria Parreira, Shayan Sharif
-
Patent number: 7173191Abstract: A cable includes a filler including a plurality of points of weakness or discontinuities spaced along its length. The points of weakness or discontinuities may be evenly spaced along the length of the cable and may be formed by partially or fully cutting through the filler. The filler may be formed from a plastics material and may be shaped, in cross section, to have a number of arms to enable it to separate other components of the cable. The filler may be electrically conductive or semi-conductive to enable it to act as screen between other components of the cable.Type: GrantFiled: April 1, 2005Date of Patent: February 6, 2007Assignee: Raydex/CDT Ltd.Inventor: Stephen John Prescott
-
Publication number: 20050186630Abstract: The invention concerns a method for rapid identification and characterization of binding partners for a target molecule, and for providing binding partners with improved binding affinity. More specifically, the invention concerns an improved tethering method for the rapid identification of at least two binding partners that bind near one another to a target molecule.Type: ApplicationFiled: April 15, 2005Publication date: August 25, 2005Inventors: Daniel Erlanson, Andrew Braisted, Robert McDowell, John Prescott
-
Patent number: 6919178Abstract: The invention concerns a method for rapid identification and characterization of binding partners for a target molecule, and for providing binding partners with improved binding affinity. More specifically, the invention concerns an improved tethering method for the rapid identification of at least two binding partners that bind near one another to a target molecule.Type: GrantFiled: November 21, 2001Date of Patent: July 19, 2005Assignee: Sunesis Pharmaceuticals, Inc.Inventors: Daniel A. Erlanson, Andrew C. Braisted, Robert McDowell, John Prescott
-
Patent number: 6888070Abstract: A cable includes a filler (12) including a plurality of points of weakness (13) or discontinuities spaced along its length. The points of weakness or discontinuities may be evenly spaced along the length of the cable and may be formed by partially or fully cutting through the filler. The filler may be formed from a plastics material and may be shaped, in cross section, to have a number of arms to enable it to separate other components of the cable. The filler may be electrically conducive or semi-conductive to enable it to act as screen between other components of the cable.Type: GrantFiled: October 16, 2000Date of Patent: May 3, 2005Assignee: Raydex/CDT LimitedInventor: Stephen John Prescott
-
Publication number: 20050084905Abstract: The invention concerns the identification of protein kinase inhibitors that preferentially bind to the inactive conformation of a target protein kinase. The inhibitors are identified by locking the target protein kinase in an inactive conformation, and using Tethering to identify inhibitors preferentially targeting the inactive conformation.Type: ApplicationFiled: September 17, 2003Publication date: April 21, 2005Inventors: John Prescott, Andrew Braisted, Joelle Morrow
-
Publication number: 20020150947Abstract: The invention concerns a method for rapid identification and characterization of binding partners for a target molecule, and for providing binding partners with improved binding affinity. More specifically, the invention concerns an improved tethering method for the rapid identification of at least two binding partners that bind near one another to a target molecule.Type: ApplicationFiled: November 21, 2001Publication date: October 17, 2002Inventors: Daniel A. Erlanson, Andrew C. Braisted, Robert McDowell, John Prescott
-
Patent number: 6408654Abstract: A filament forming apparatus and cooling apparatus for and method of inducing a uniform air flow between a filament forming area beneath a bushing and the cooling apparatus are disclosed. The cooling apparatus includes an air housing extending beneath the bushing. The air housing has a top wall and side walls defining an air chamber therebetween.Type: GrantFiled: June 9, 1999Date of Patent: June 25, 2002Assignee: Owens Corning Fiberglas Technology, Inc.Inventors: Douglas Scott Boessneck, Guang Gao, David Herman Wolf, Andrew Lawrence Snedden, Patrick John Prescott, Seshadri Srinivasan, Jeffrey Coon
-
Patent number: 5089914Abstract: A thermal camera is mounted within a helmet and is arranged such that the optical path in free space from its output is wholly within the volume defined by the helmet and the helmet faceplate. The output iminges on a concave mirror/lens combination located below the wearer's sightline. The arrangement is particularly suitable for fire fighting and search and rescue applications.Type: GrantFiled: September 27, 1990Date of Patent: February 18, 1992Assignee: EEV LimitedInventor: John A. Prescott